Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation

Background Previous randomized control trials showed mixed results concerning the effect of omega‐3 fatty acids (n‐3 FAs) on atrial fibrillation (AF). The associations of n‐3 FA blood levels with heart rhythm in patients with established AF are unknown. The goal of this study was to assess the assoc...

Full description

Saved in:
Bibliographic Details
Main Authors: Philipp Baumgartner, Martin F. Reiner, Andrea Wiencierz, Michael Coslovsky, Nicole R. Bonetti, Mark G. Filipovic, Stefanie Aeschbacher, Michael Kühne, Christine S. Zuern, Nicolas Rodondi, Jolanda Oberle, Giorgio Moschovitis, Thomas F. Lüscher, Giovanni G. Camici, Stefan Osswald, David Conen, Jürg H. Beer
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.027646
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850273635896393728
author Philipp Baumgartner
Martin F. Reiner
Andrea Wiencierz
Michael Coslovsky
Nicole R. Bonetti
Mark G. Filipovic
Stefanie Aeschbacher
Michael Kühne
Christine S. Zuern
Nicolas Rodondi
Jolanda Oberle
Giorgio Moschovitis
Thomas F. Lüscher
Giovanni G. Camici
Stefan Osswald
David Conen
Jürg H. Beer
author_facet Philipp Baumgartner
Martin F. Reiner
Andrea Wiencierz
Michael Coslovsky
Nicole R. Bonetti
Mark G. Filipovic
Stefanie Aeschbacher
Michael Kühne
Christine S. Zuern
Nicolas Rodondi
Jolanda Oberle
Giorgio Moschovitis
Thomas F. Lüscher
Giovanni G. Camici
Stefan Osswald
David Conen
Jürg H. Beer
author_sort Philipp Baumgartner
collection DOAJ
description Background Previous randomized control trials showed mixed results concerning the effect of omega‐3 fatty acids (n‐3 FAs) on atrial fibrillation (AF). The associations of n‐3 FA blood levels with heart rhythm in patients with established AF are unknown. The goal of this study was to assess the associations of total and individual n‐3 FA blood levels with AF type (paroxysmal versus nonparoxysmal), heart rate (HR), and HR variability in patients with AF. Methods and Results Total n‐3 FAs, eicosapentaenoic acid, docosahexaenoic acid, docosapentaenoic acid, and alpha‐linolenic acid blood levels were determined in 1969 patients with known AF from the SWISS‐AF (Swiss Atrial Fibrillation cohort). Individual and total n‐3 FAs were correlated with type of AF, HR, and HR variability using standard logistic and linear regression, adjusted for potential confounders. Only a mild association with nonparoxysmal AF was found with total n‐3 FA (odds ratio [OR], 0.97 [95% CI, 0.89–1.05]) and docosahexaenoic acid (OR, 0.93 [95% CI, 0.82–1.06]), whereas other individual n‐3 FAs showed no association with nonparoxysmal AF. Higher total n‐3 FAs (estimate 0.99 [95% CI, 0.98–1.00]) and higher docosahexaenoic acid (0.99 [95% CI, 0.97–1.00]) tended to be associated with slower HR in multivariate analysis. Docosapentaenoic acid was associated with a lower HR variability triangular index (0.94 [95% CI, 0.89–0.99]). Conclusions We found no strong evidence for an association of n‐3 FA blood levels with AF type, but higher total n‐3 FA levels and docosahexaenoic acid might correlate with lower HR, and docosapentaenoic acid with a lower HR variability triangular index.
format Article
id doaj-art-3a47f5c745eb4930ba4ac0829140726d
institution OA Journals
issn 2047-9980
language English
publishDate 2023-06-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-3a47f5c745eb4930ba4ac0829140726d2025-08-20T01:51:25ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802023-06-01121110.1161/JAHA.122.027646Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial FibrillationPhilipp Baumgartner0Martin F. Reiner1Andrea Wiencierz2Michael Coslovsky3Nicole R. Bonetti4Mark G. Filipovic5Stefanie Aeschbacher6Michael Kühne7Christine S. Zuern8Nicolas Rodondi9Jolanda Oberle10Giorgio Moschovitis11Thomas F. Lüscher12Giovanni G. Camici13Stefan Osswald14David Conen15Jürg H. Beer16Department of Internal Medicine Cantonal Hospital of Baden Baden SwitzerlandDepartment of Internal Medicine Cantonal Hospital of Baden Baden SwitzerlandClinical Trial Unit, University Hospital of Basel Basel SwitzerlandClinical Trial Unit, University Hospital of Basel Basel SwitzerlandDepartment of Internal Medicine Cantonal Hospital of Baden Baden SwitzerlandDepartment of Anaesthesiology and Pain Medicine, Inselspital Bern University Hospital, University of Bern SwitzerlandDepartment of Cardiology University Hospital of Basel Basel SwitzerlandDepartment of Cardiology University Hospital of Basel Basel SwitzerlandDepartment of Cardiology University Hospital of Basel Basel SwitzerlandDepartment of General Internal Medicine Bern University Hospital, University of Bern SwitzerlandDepartment of General Internal Medicine Bern University Hospital, University of Bern SwitzerlandDivision of Cardiology, Ende Ospedaliero Cantonale (EOC) Ospedale Regionale di Lugano Lugano SwitzerlandRoyal Brompton and Harefield Hospitals London UKCenter for Molecular Cardiology University of Zurich Schlieren SwitzerlandDepartment of Cardiology University Hospital of Basel Basel SwitzerlandPopulation Health Research Institute McMaster University Hamilton CanadaDepartment of Internal Medicine Cantonal Hospital of Baden Baden SwitzerlandBackground Previous randomized control trials showed mixed results concerning the effect of omega‐3 fatty acids (n‐3 FAs) on atrial fibrillation (AF). The associations of n‐3 FA blood levels with heart rhythm in patients with established AF are unknown. The goal of this study was to assess the associations of total and individual n‐3 FA blood levels with AF type (paroxysmal versus nonparoxysmal), heart rate (HR), and HR variability in patients with AF. Methods and Results Total n‐3 FAs, eicosapentaenoic acid, docosahexaenoic acid, docosapentaenoic acid, and alpha‐linolenic acid blood levels were determined in 1969 patients with known AF from the SWISS‐AF (Swiss Atrial Fibrillation cohort). Individual and total n‐3 FAs were correlated with type of AF, HR, and HR variability using standard logistic and linear regression, adjusted for potential confounders. Only a mild association with nonparoxysmal AF was found with total n‐3 FA (odds ratio [OR], 0.97 [95% CI, 0.89–1.05]) and docosahexaenoic acid (OR, 0.93 [95% CI, 0.82–1.06]), whereas other individual n‐3 FAs showed no association with nonparoxysmal AF. Higher total n‐3 FAs (estimate 0.99 [95% CI, 0.98–1.00]) and higher docosahexaenoic acid (0.99 [95% CI, 0.97–1.00]) tended to be associated with slower HR in multivariate analysis. Docosapentaenoic acid was associated with a lower HR variability triangular index (0.94 [95% CI, 0.89–0.99]). Conclusions We found no strong evidence for an association of n‐3 FA blood levels with AF type, but higher total n‐3 FA levels and docosahexaenoic acid might correlate with lower HR, and docosapentaenoic acid with a lower HR variability triangular index.https://www.ahajournals.org/doi/10.1161/JAHA.122.027646atrial fibrillationheart rateheart rate variabilityomega‐3 fatty acidrhythm type
spellingShingle Philipp Baumgartner
Martin F. Reiner
Andrea Wiencierz
Michael Coslovsky
Nicole R. Bonetti
Mark G. Filipovic
Stefanie Aeschbacher
Michael Kühne
Christine S. Zuern
Nicolas Rodondi
Jolanda Oberle
Giorgio Moschovitis
Thomas F. Lüscher
Giovanni G. Camici
Stefan Osswald
David Conen
Jürg H. Beer
Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
atrial fibrillation
heart rate
heart rate variability
omega‐3 fatty acid
rhythm type
title Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
title_full Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
title_fullStr Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
title_full_unstemmed Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
title_short Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
title_sort omega 3 fatty acids and heart rhythm rate and variability in atrial fibrillation
topic atrial fibrillation
heart rate
heart rate variability
omega‐3 fatty acid
rhythm type
url https://www.ahajournals.org/doi/10.1161/JAHA.122.027646
work_keys_str_mv AT philippbaumgartner omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT martinfreiner omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT andreawiencierz omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT michaelcoslovsky omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT nicolerbonetti omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT markgfilipovic omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT stefanieaeschbacher omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT michaelkuhne omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT christineszuern omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT nicolasrodondi omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT jolandaoberle omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT giorgiomoschovitis omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT thomasfluscher omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT giovannigcamici omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT stefanosswald omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT davidconen omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation
AT jurghbeer omega3fattyacidsandheartrhythmrateandvariabilityinatrialfibrillation